Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Atten Defic Hyperact Disord. 2016 Nov 19;9(1):47–65. doi: 10.1007/s12402-016-0208-3

Table 5.

Associations of childhood ADHD subtypes with comorbid lifetime DSM-IV/CIDI disorders, in all countries combined (n = 26,744)

Active versus remitted ADHD
Remitted childhood AD-only
Remitted childhood HD
OR (95% CI) OR (95% CI) OR (95% CI)
I. Mood disorders
 Major depressive disorder 1.2 (1.0–1.6) 2.0* (1.6–2.5) 1.7* (1.3–2.2)
 Bipolar 2.0* (1.3–2.9) 1.7* (1.0–2.8) 2.3* (1.5–3.6)
II. Anxiety disorders
 Panic or agoraphobia 1.5 (1.0–2.1) 1.9* (1.2–2.9) 1.6* (1.1–2.6)
 General anxiety disorder 1.6 (1.0–2.7) 1.4 (0.8–2.5) 1.9* (1.1–3.4)
 Specific phobia 1.9* (1.1–3.3) 1.3 (0.7–2.2) 1.2 (0.7–2.2)
 Social phobia 1.7* (1.0–2.7) 1.6 (1.0–2.7) 1.3 (0.8–2.3)
III. Substance use disorders
 Alcohol abuse with or without dependence 1.3 (0.9–1.7) 2.0* (1.5–2.8) 2.2* (1.6–2.9)
 Drug abuse with or without dependence 1.4* (1.1–2.0) 2.0* (1.4–3.0) 2.7* (1.8–4.0)
IV. Behavior disorders
 Intermittent explosive disorder 2.7* (1.7–4.4) 1.1 (0.7–1.8) 1.2 (0.7–2.1)
 Oppositional defiant disorder 4.6* (1.7–12.1) 0.8 (0.3–2.3) 1.1 (0.4–2.8)

All models are person-year models assessed with part II weight (except Iraq and Romania), controlling for time-invariant dummies for country, sex, dummy for threshold childhood ADHD, time-varying continuous age, age-squared, and dummy active (time-varying dummy for whether the int is less than or equal to the age of recency of ADHD)

*

Significant at the .05 level, two-sided test